These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22522559)

  • 1. Atypical "black hole" phenomenon after treatment of sirolimus stent restenosis with a paclitaxel-coated balloon.
    Linares Vicente JA; Lukic A; Gonzalo López N; Ruiz Arroyo JR
    EuroIntervention; 2012 Apr; 7(12):1479. PubMed ID: 22522559
    [No Abstract]   [Full Text] [Related]  

  • 2. Optical coherence tomography (OCT) evaluation after coronary stenting: the "black hole" and other low OCT signal-intensity areas.
    Landmesser U
    EuroIntervention; 2012 Apr; 7(12):1367-71. PubMed ID: 22522547
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation inhibitory effects of sirolimus and paclitaxel-eluting stents on interleukin-1β-induced coronary artery in-stent restenosis in pigs.
    Zhou XC; Huang RC; Zhang B; Yin D; Liang B; Wang SP; Guan QG; Sun XZ; Miao ZL; He XZ; Han FT; Cheng Y; Zhang L; Zeng DY
    Chin Med J (Engl); 2010 Sep; 123(17):2405-9. PubMed ID: 21034557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
    Farooq V; Gogas BD; Serruys PW
    Circ Cardiovasc Interv; 2011 Apr; 4(2):195-205. PubMed ID: 21505166
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
    Yoneyama K; Koyama K; Tanabe Y; Mitarai T; Kamijima R; Kuwata S; Yamazaki H; Nakano E; Kongoji K; Harada T; Akashi YJ
    Int J Cardiol; 2014 Oct; 176(3):1207-9. PubMed ID: 25129263
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial optical coherence tomography imaging of the "black-hole" phenomenon by intravascular ultrasound following sirolimus-eluting stent implantation.
    Kurita T; Terashima M; Suzuki T
    EuroIntervention; 2012 Apr; 7(12):1480-1. PubMed ID: 22522560
    [No Abstract]   [Full Text] [Related]  

  • 8. Extremely Late Catch-Up Phenomenon After First-Generation Sirolimus-Eluting Stent in the Left Main Stem: Insights From Optical Coherence Tomography.
    Naganuma T; Fujino Y; Tahara S; Mitomo S; Basavarajaiah S; Nakamura S
    JACC Cardiovasc Interv; 2015 Dec; 8(14):e237-9. PubMed ID: 26718525
    [No Abstract]   [Full Text] [Related]  

  • 9. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiographically silent very late stent thrombosis detected by optical coherence tomography in association with peri-stent staining and multiple interstrut cavities.
    Cassar A; Gulati R; Matsuo Y; Bresnahan JF; Prasad A
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):603. PubMed ID: 23258315
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation.
    Takano M; Xie Y; Murakami D; Inami S; Yamamoto M; Ohba T; Seino Y; Mizuno K
    Int J Cardiol; 2009 May; 134(2):263-5. PubMed ID: 18403032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-flow phenomenon after Paclitaxel-coated balloon angioplasty: findings from optical coherence tomography and coronary angioscopy.
    Ikenaga H; Kurisu S; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    JACC Cardiovasc Interv; 2015 Apr; 8(4):e59-62. PubMed ID: 25819189
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
    Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
    Park DW; Kim YH; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Seong IW; Lee JH; Tahk SJ; Jeong MH; Jang Y; Cheong SS; Yang JY; Lim DS; Seung KB; Chae JK; Hur SH; Lee SG; Yoon J; Lee NH; Choi YJ; Kim HS; Kim KS; Kim HS; Hong TJ; Park HS; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(15):1187-95. PubMed ID: 20883925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty.
    Suzuki S; Nakatani S; Sotomi Y; Shiojima I; Sakata Y; Higuchi Y
    J Int Med Res; 2020 Jan; 48(1):300060519837445. PubMed ID: 30938569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
    Piraino D; Buccheri D; Cimino G; Andolina G
    Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of fragmented balloon materials in coronary arteries by optical coherence tomography.
    Adoni NA; Huang GW; Rangasetty UC; Gilani S; Fujise K
    JACC Cardiovasc Interv; 2014 Jun; 7(6):e65-6. PubMed ID: 24947730
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.